GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapport Therapeutics Inc (NAS:RAPP) » Definitions » Cash From Discontinued Investing Activities

RAPP (Rapport Therapeutics) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Rapport Therapeutics Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Rapport Therapeutics's cash from discontinued investing activities for the three months ended in Sep. 2024 was $0.00 Mil. It means Rapport Therapeutics received $0.00 Mil from discontinued investing activities. Rapport Therapeutics's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Rapport Therapeutics Cash From Discontinued Investing Activities Historical Data

The historical data trend for Rapport Therapeutics's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapport Therapeutics Cash From Discontinued Investing Activities Chart

Rapport Therapeutics Annual Data
Trend Dec22 Dec23
Cash From Discontinued Investing Activities
- -

Rapport Therapeutics Quarterly Data
Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash From Discontinued Investing Activities Get a 7-Day Free Trial - - - - -

Rapport Therapeutics Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapport Therapeutics Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Rapport Therapeutics's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapport Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapport Therapeutics Inc (NAS:RAPP) » Definitions » Cash From Discontinued Investing Activities
Comparable Companies
TECX CGEM HUMA CVAC OCS TYRA OMER KURA ERAS DNTH VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
1325 Boylston Street, Suite 401, Boston, MA, USA, 02215
Website
https://www.rapportrx.com
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.